Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.
Mouret-Reynier MA, Abrial CJ, Ferrière JP, Amat S, Curé HD, Kwiatkowski FG, Feillel VA, Lebouëdec G, Penault-Llorca FM, Chollet PJ.
Mouret-Reynier MA, et al. Among authors: amat s.
Clin Breast Cancer. 2004 Oct;5(4):303-7. doi: 10.3816/cbc.2004.n.035.
Clin Breast Cancer. 2004.
PMID: 15507178
Clinical Trial.